Addiction Therapist

Celeste Apodaca, LAC, LPCC

8355 E 32nd Ave Apt 315, Denver, Colorado, 80238-4433

About Celeste Apodaca

Celeste Apodaca is a therapist based in Denver, Colorado who is specialized in Addiction (Substance Use Disorder) Counselor. Active license number of Celeste Apodaca is ACD.0002739 for Addiction (Substance Use Disorder) Counselor in Colorado. Her current practice location is 8355 E 32nd Ave Apt 315, Denver. Patients can reach her at 303-261-6377 or can fax her at 303-261-6377. Celeste Apodaca is LAC, LPCC in Addiction (Substance Use Disorder) Counselor and her NPI number (Unique professional ID assigned by NPPES) is 1952876112.

Celeste Apodaca is a licensed mental health therapist who help individuals struggling with addiction of alcohol, drug, or other substance use disorder. She helps her clients by manage and overcome the psychological, emotional, and behavioral challenges related to substance use. Counselors also work closely with families and support systems to help them better understand their loved one’s illness. SUD counselors help to promote long-term sobriety, emotional stability, and overall mental wellness for both the individual and their family.

Practice Information

Celeste Apodaca speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for appointment.

Provider Name Celeste Apodaca
Specialization Addiction (Substance Use Disorder) Counselor
Credentials LAC, LPCC
Gender Female
Practice Address: 8355 E 32nd Ave Apt 315,
Denver, CO - 80238-4433
Fax 303-261-6377

Professional Identification Codes

NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS). NPI details are as mentioned below.

NPI Number1952876112
NPI Enumeration Date: 03 Oct, 2018
NPI Last Update On: 27 May, 2025

Medical Licenses:

Healthcare professionals can hold one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Celeste Apodaca are as mentioned below.

License NumberSpecializationStateStatus
ACD.0002739Addiction (Substance Use Disorder) Counselor ColoradoPrimary

Mailing Address

Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned Practice address.

Celeste Apodaca
8355 E 32nd Ave Apt 315,
Denver, CO - 80238-4433
Phone: 303-261-6377

Book an Appointment with Celeste Apodaca

To schedule an appointment, contact Celeste Apodaca at 8355 E 32nd Ave Apt 315, Denver, Colorado or call on below stated phone number.

Call to Book an Appointment

Frequently Asked Questions

Below are some commonly asked questions about Celeste Apodaca:

Celeste Apodaca is a therapist specializing in Addiction (Substance Use Disorder) Counselor. She is a licensed mental health therapist who help individuals struggling with addiction of alcohol, drug, or other substance use disorder. She helps her clients by manage and overcome the psychological, emotional, and behavioral challenges related to substance use. Counselors also work closely with families and support systems to help them better understand their loved one’s illness. SUD counselors help to promote long-term sobriety, emotional stability, and overall mental wellness for both the individual and their family.

Yes, Celeste Apodaca is currently accepting new patients. To schedule an appointment, contact the office directly and schedule an appointment.

Celeste Apodaca practices at 8355 E 32nd Ave Apt 315, Denver, Colorado, 80238-4433.

To schedule an appointment with Celeste Apodaca, please contact the office at 303-261-6377.

Reviews & Feedback

Have you visited Celeste Apodaca? Share your experience to help others looking for a Addiction (Substance Use Disorder) Counselor in Denver, CO.

Read Reviews / Give Feedback
**Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 14 September, 2026.